$7700 | Site License
$16900 | Global License

Future Horizons and Growth Strategies in the Japanese Blood Banking Market: Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities
[Report Updated: 02-08-2016]

Published by Venture Planning Group (VPG): 02 Aug 2016 | 60088 | In Stock
Related Topics: Blood , Hepatitis , Infectious Disease

Introduction

Complete report ,700.  DataPack (test volumes, sales forecasts, supplier shares) ,950.

VPG Market Research's new strategic analysis is prepared in order to help current suppliers and potential market entrants identify and evaluate emerging opportunities and assist industry executives in developing effective business, new product development and marketing strategies. 
 
Rationale

During the next five years, the Japanese blood banking market is expected to undergo significant transformation, which will result from the convergence of several trends, including more stringent regulations; advances in diagnostic technologies, IT, system engineering and automation; and intensifying competition.  Some segments will start resembling commodity markets, where product positioning and differentiation are more critical than underlying technology. 

The changes in the marketplace will create exciting opportunities for new instruments and reagent systems, as well as auxiliary products, such as specimen preparation devices, controls, calibrators, and innovative IT applications.

Strategic Recommendations

- New product development opportunities with significant market appeal.
- Alternative market penetration strategies.
- Potential market entry barriers and risks.

The report explores future marketing and technological trends in the Japan; provides estimates of the test volume, instrument placements and sales; compares features of major automated and semi-automated analyzers; profiles leading and emerging competitors; and identifies specific product and market opportunities facing suppliers during the next ten years.

Blood Typing and Grouping Tests

ABO, Antibody Panels, Antibody Screening/Indirect Antiglobulin,
Antigen Typing (C, c, Duffy, E, e, I, i, Kell, Kidd, Le a, b, MN, P, S, s),
Antiglobulin (Direct, C3 + IgG, IgG,  C3),
Crossmatching (Immediate Spin, Full Crossmatch), Rh (D, Du).

Infectious Disease Screening Tests

AIDS (HIV NAT, HIV-1/2), Cytomegalovirus,
Hepatitis (HAV NAT, HBV NAT, HBs Ag,  
Anti-HBc, HCV NAT, HCV, ALT/SGPT), HTLV-I/II, Parvovirus B19 NAT,
Syphilis, West Nile Virus NAT.

Sales and Market Share Analysis

Sales and market share estimates of leading
suppliers of blood banking of reagents
and instruments, by individual product.

Competitive Assessments

Strategic assessments of major suppliers and
emerging market entrants, including their sales,
product portfolios, marketing tactics, and new
products in R&D.

Market Segmentation Analysis

- Comprehensive market segmentation
analysis, including review of the market
dynamics, trends, structure, size, growth,
and key suppliers.

- Test volume and sales forecasts for over 40
blood banking tests, including NAT, by market segment:

- Blood Centers
- Hospitals
- Commercial/Private Laboratories

Current and Emerging Products

- Analysis of current and emerging blood banking tests.

- Review of automated and semi-automated
analyzers, including their operating
characteristics, features, and selling prices.

Technology Review

- Assessment of current and emerging technologies,
and their potential applications for the blood banking market.

- Comprehensive lists of companies developing
or marketing new technologies and products by test.

Contains 426 pages and 41 tables

Table of Contents
for Future Horizons and Growth Strategies in the Japanese Blood Banking Market: Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities [Report Updated: 02-08-2016]

  • Table of Content - click REQUEST A SAMPLE BUTTON

List Of Tables
in Future Horizons and Growth Strategies in the Japanese Blood Banking Market: Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities [Report Updated: 02-08-2016]

Competitive Assessments

- Abbott

- Beckman Coulter/Danaher

- Becton Dickinson

- Biokit

- BioMerieux

- Bio-Rad

- CellMark Forensics/LabCorp

- Diagast

- DiaSorin

- Fujirebio

- Grifols

- Hologic/Gen-Probe

- Immucor

- Ortho-Clinical Diagnostic

- Proteome Sciences

- Quest

- Quidel

- Roche

- Siemens

- Tecan

- Thermo Fisher/Life Technologies

Additional Details

Publisher

Venture Planning Group (VPG)

Publisher Information

Reference

60088 | VPBB20249

Number of Pages

426

Report Format

PDF

Venture Planning Group (VPG) Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Designs on the Future of Health: The ambitions of Google, Apple, et al
IntroductionThe digital health revolution: tech giants and their impact on pharmaDrug discovery, qui...
01 Mar 2016 by FirstWord Pharma USD $695 More Info
The Future of Biosimilars 2015
IntroductionThe Future of Biosimilars 2015 offers expert insight and opinion on the key issues facin...
01 Jun 2015 by FirstWord Pharma USD $2,195 More Info
Orphan Drug Market Access: Payer Insights on the Present and Future
IntroductionOrphan Drug Market Access: Payer Insights on the Present and Future is a report that exa...
14 Oct 2014 by FirstWord Pharma USD $695 More Info
The Future of Cancer Immunotherapy: KOL Views Bring Opportunities into Sharp Focus
IntroductionThere has been considerable media hype and clinical interest in cancer immunotherapy in ...
01 Jul 2014 by FirstWord Pharma USD $4,995 More Info
Physician Views: What does the future hold for new EGFR targeting NSCLC therapies?
Scope Propelled via momentum from new data presented at the ASCO annual meeting, AstraZeneca's AZD-9...
19 Jun 2014 by FirstWord Pharma USD $695 More Info
The Future of Biosimilars: mapping critical uncertainties and the impact of future events
IntroductionThe Future of Biosimilars: Mapping Critical Uncertainties and the Impact of Future Event...
05 May 2014 by FirstWord Pharma USD $1,950 More Info
Physician Views: What future for wearable health technology?
Scope As the patient becomes a more proactive stakeholder in the healthcare sphere and the developme...
24 Apr 2014 by FirstWord Pharma USD $695 More Info
Physician Views: What role will device development play in the future GLP-1 agonist market?
Scope Positioned frequently as a transitional diabetes therapy between oral agents and insulin – and...
07 Mar 2014 by FirstWord Pharma USD $695 More Info
Pharma's Future Role in CME
IntroductionOver the last 10 years, every aspect of continuing medical education (CME) has endured m...
01 Aug 2012 by FirstWord Pharma USD $695 More Info
Branded Generics in South East Asia: Current and Future Opportunities
IntroductionWith its fast-growing, young population and projected pharmaceutical sales in excess of ...
01 Apr 2012 by FirstWord Pharma USD $945 More Info

This report is published by Venture Planning Group (VPG)

Download Free Report Summary PDF

Future Horizons and Growth Strategies in the Japanese Blood Banking Market: Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities [Report Updated: 02-08-2016] | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...